Navigation Links
Sanofi-aventis US Chairman Tim Rothwell Addresses CMSA's Collaborative Practice Summit
Date:10/9/2007

Rothwell Shared Personal Experiences and sanofi-aventis' Goal to be Part of

the Solution for Improving Collaboration Among Stakeholders

LITTLE ROCK, Ark., Oct. 9 /PRNewswire-FirstCall/ -- Tim Rothwell, Chairman, Group Pharmaceutical Activities, sanofi-aventis, U.S., delivered an address at the Collaborative Practice Summit (CPS) hosted by the Case Management Society of America (CMSA) and held October 3-5 in Uncasville, Conn.

CPS brought together a focused group of more than 125 healthcare professionals to discuss leading-edge collaboration models that explored benchmarks for measurement. Rothwell shared personal experiences regarding transitions-of-care issues with CPS attendees and discussed sanofi-aventis' commitment to be part of the solution for improving collaboration among all healthcare stakeholders.

Rothwell complimented the group for tackling a difficult, yet extremely important, issue. "We talk a lot about 'breaking down silos' in healthcare," Rothwell said. "At this Collaborative Practice Summit, you've assembled a group of healthcare leaders who are committed to doing exactly that. The very name of the event - the 'Collaborative Practice Summit' - has the ring of possibility in it. It suggests many perspectives coming together as one to solve a problem."

The issues and challenges of poor transitions of care, said Rothwell, are critically important to him personally and to sanofi-aventis as a company. "The problem, of course, is a healthcare system that, for many - particularly those who get bounced around within it - is fragmented and sometimes even frightening," Rothwell observed. "For those who have family members or friends who have experienced repeated encounters with the healthcare system, the only consistent thing they believe it delivers is confusion and, sometimes, flawed outcomes."

According to Rothwell, a root cause of the problem is the way today's current healthcare system encourages and builds silo
'/>"/>

SOURCE sanofi-aventis; CMSA
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. Ontario Addresses Shortage of Transplant Organs
5. Special Section of JCS Addresses Vascular Anomalies
6. AutoGenomics Addresses TB Crisis With a Genetic Drug Resistance Test
7. WHO And China Set Up Collaborative Center For Fighting Bird Flu
8. Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend
9. Medarex Announces Collaborative Research Agreement With Mitsubishi Pharma
10. Indian Nationals with Foreign Medical Degrees can now practice in India
11. Researchers Feel The Need For Standards Of Practice In Immunoglobulin Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...-Everest Team has announced at the Cheltenham Scie...edition team to mount Everest to conduct //a resea... Doctors and scientists from the Centre for Aviat...dicine at the Institute of Human Health and Perfor...
...through move against HIV drug resistance, scientis...aturation Inhibitors that is the first in a new cl...nt the formation of Caspsid, a key viral protein f...rug in question, PA- 457, is a derivative of betul...
... Thwala, the Ministry of Agriculture Director of V...President of the African Regional Commission //for...tion for Animal Health (OIE). Dr. Barry O’Neil wa.... This post is held for three years. The elections...
... is enthralling people with his magic tricks or de...fessor Gursharan Singh Chhatwal does both with eas... a gifted magician. But the scientist from India h...is work against the killer streptococci bacteria. ...
Other Medicine News:Health News:Mount Everest to be Site of Research into Hypoxia 2Health News:Indian Scientist who Enthralls Public With Magic Tricks 2
(Date:10/13/2008)... January 2009 and Final Trial .... 13 /- Neurobiological,Tec...nounced that following a,meeting with the U.S. Foo...TM) (ancrod) Phase 3 clinical program for acute is...d analyze data from its two concurrently,running d...
(Date:10/12/2008)...ewswire-FirstCall/ -- Boston,Scientific Corporatio...alysis,of nearly 7,500 patients from its TAXUS ARR...irm the performance of the TAXUS(R) Express2(TM),P...rld practice. The,two-year pooled ARRIVE data show...s in patients with diabetes as effectively as in p...
(Date:10/10/2008)...ll/ -- Boston Scientific,Corporation (NYSE: BSX )...or,events and press announcements at the Cardiovas... Transcatheter Cardiovascular Therapeutics (TCT),s... 17 in Washington, D.C., Boston Scientific will b...ata on its TAXUS(R) Express2(TM) and second-genera...
(Date:10/9/2008)...mber 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fir...ced today the completion of patient enrollment and...to evaluate the safety and,efficacy of its formula...r,the over-the-counter (OTC) market. The Company e...l trial in November 2008. Ibuprofen is an analgesi...
Breaking Medicine Technology:Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Hill Rom to Present at the Citi Healthcare Conference 18778 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 15th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 18775 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 1Met Pro Corporation to Report First Quarter Earnings on May 22 18772 2Met Pro Corporation to Report First Quarter Earnings on May 22 18772 3Mangos Captures 11 HMR Awards 18769 1Mangos Captures 11 HMR Awards 18769 2
Humerus Fracture Brace indications: , Nonoperative treatment of closed humeral shaft fractures , Postoperative treatment of open humeral shaft fractures , Protection of humeral defects , After rem
The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion
...This simple concept is the cornerstone of our Town...k the heel with our patent-pending Stablelock Syst...t your patient will experience walking in their TS... and supports the posterior aspect of the leg. Thi...
Medicine Products: